UK markets closed
  • FTSE 100

    6,915.75
    -26.47 (-0.38%)
     
  • FTSE 250

    22,251.26
    +3.72 (+0.02%)
     
  • AIM

    1,236.50
    -2.54 (-0.21%)
     
  • GBP/EUR

    1.1510
    -0.0012 (-0.11%)
     
  • GBP/USD

    1.3706
    -0.0029 (-0.21%)
     
  • BTC-GBP

    44,137.23
    +1,199.59 (+2.79%)
     
  • CMC Crypto 200

    1,235.89
    +8.34 (+0.68%)
     
  • S&P 500

    4,128.80
    +31.63 (+0.77%)
     
  • DOW

    33,800.60
    +297.03 (+0.89%)
     
  • CRUDE OIL

    59.34
    -0.26 (-0.44%)
     
  • GOLD FUTURES

    1,744.10
    -14.10 (-0.80%)
     
  • NIKKEI 225

    29,768.06
    +59.08 (+0.20%)
     
  • HANG SENG

    28,698.80
    -309.27 (-1.07%)
     
  • DAX

    15,234.16
    +31.48 (+0.21%)
     
  • CAC 40

    6,169.41
    +3.69 (+0.06%)
     

LabVantage Adds Vendor Validation to Its Software-as-a-Service LIMS

·3-min read

—Introduces Vendor Validation to Its SaaS LIMS—
—Validation Addresses Unique Needs of Organizations in Sectors with Stringent Regulatory Requirements—
—Validation Documents That the System Meets Optimal Standards for Data Integrity and Control—

LabVantage Solutions, Inc., the leading provider of laboratory informatics solutions and services including purpose-built LIMS solutions that allow labs to go live faster and at a lower total cost, today announced it has added validation to a number of its subscription-based LIMS. Adding validation support to a cloud-hosted, Software-as-a-Service (SaaS) LIMS increases confidence for organizations that function in regulated sectors, such as pharmaceuticals, biobanking, and clinical and molecular diagnostics.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210308005005/en/

Pre-packaged LabVantage LIMS that now offer SaaS validation are LabVantage Pharma, LabVantage Biobanking, and LabVantage COVID-19 LIMS.

"Having a validated SaaS LIMS ensures the delivered system is managed and maintained in a controlled, risk-aware manner," said Jeff Vannest, Senior Director of Product Management at LabVantage Solutions. "LabVantage assumes responsibility for changes made to the software during feature enhancements, upgrades, and updates. Every alteration is fully documented, tested, and reported to our customers."

Evidence of validated control is essential when a company must report to the FDA or a similar regulatory body. Validation presents a formal record that the installed software is held to the highest possible standard in terms of data integrity and control and the responsibility rests with the vendor.

Like other types of SaaS products, LabVantage’s validated SaaS LIMS meets the growing needs of organizations that want to move beyond the traditional models of licensing, installation, maintenance, and management of software in favor of an application from a vendor that accepts responsibility for back-end security, availability, and performance.

LabVantage’s validated SaaS LIMS can be configured as pre-packaged, industry-specific solutions that address unique workflows, which right-sizes the LIMS for an organization, eliminates the need for customization, accelerates adoption and deployment, and reduces risk and total costs.

With LabVantage SaaS, customers pay an annual subscription fee to access the entire LabVantage platform—LIMS, electronic laboratory notebook, laboratory execution system, and scientific data management system. Validated software updates are routinely implemented by LabVantage, freeing up customers’ internal resources and increasing productivity. The system is highly scalable and allows customers to pay only for what they need and use. It is a flexible option that makes it easy for customers to add features and capacity as they grow.

Additionally, a vendor-validated SaaS LIMS allows customers to expand the system to other locations, subsidiaries, and partners with confidence.

For more information on LabVantage SaaS LIMS, click here, watch the video here, or email info@labvantage.com.

About LabVantage Solutions

A recognized leader in enterprise laboratory software solutions, LabVantage Solutions dedicates itself to improving customer outcomes by transforming data into knowledge. The LabVantage informatics platform is highly configurable, integrated across a common architecture, and 100% browser-based to support hundreds of concurrent users. Deployed on-premise, via the cloud, or SaaS, it seamlessly interfaces with instruments and other enterprise systems – enabling true digital transformation. The platform consists of the most modern laboratory information management system (LIMS) available, integrated electronic laboratory notebook (ELN), laboratory execution system (LES), scientific data management system (SDMS), and advanced analytics; and, for healthcare settings, a laboratory information system (LIS). We support more than 1500 global customer sites in the life sciences, pharmaceutical, medical device, biobank, food & beverage, consumer packaged goods, oil & gas, genetics/diagnostics, and healthcare industries. Headquartered in Somerset, NJ, with global offices, LabVantage has offered its comprehensive portfolio of products and services to enable customers to innovate faster in the R&D cycle, improve manufactured product quality, achieve accurate record-keeping, and comply with regulatory requirements for four decades. For more information, visit labvantage.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210308005005/en/

Contacts

Media:
Brandwidth Solutions LLC
Debra Harrsch
Phone: 215-997-8575
Email: dharrsch@BWSmarketing.com